- Home
- JMIA vs ALMS Comparison
JMIA vs ALMS Comparison
Compare JMIA & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMIA
- ALMS
- Stock Information
- Founded
- JMIA 2012
- ALMS 2021
- Country
- JMIA Germany
- ALMS United States
- Employees
- JMIA N/A
- ALMS N/A
- Industry
- JMIA Catalog/Specialty Distribution
- ALMS
- Sector
- JMIA Consumer Discretionary
- ALMS
- Exchange
- JMIA Nasdaq
- ALMS NYSE
- Market Cap
- JMIA 573.4M
- ALMS 469.0M
- IPO Year
- JMIA 2019
- ALMS 2024
- Fundamental
- Price
- JMIA $4.56
- ALMS $8.74
- Analyst Decision
- JMIA Buy
- ALMS Strong Buy
- Analyst Count
- JMIA 3
- ALMS 6
- Target Price
- JMIA $6.53
- ALMS $29.60
- AVG Volume (30 Days)
- JMIA 4.0M
- ALMS 134.8K
- Earning Date
- JMIA 11-07-2024
- ALMS 11-13-2024
- Dividend Yield
- JMIA N/A
- ALMS N/A
- EPS Growth
- JMIA N/A
- ALMS N/A
- EPS
- JMIA N/A
- ALMS N/A
- Revenue
- JMIA $181,204,000.00
- ALMS N/A
- Revenue This Year
- JMIA $3.80
- ALMS N/A
- Revenue Next Year
- JMIA $5.50
- ALMS N/A
- P/E Ratio
- JMIA N/A
- ALMS N/A
- Revenue Growth
- JMIA 3.61
- ALMS N/A
- 52 Week Low
- JMIA $2.88
- ALMS $7.66
- 52 Week High
- JMIA $15.04
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- JMIA 54.30
- ALMS N/A
- Support Level
- JMIA $4.22
- ALMS N/A
- Resistance Level
- JMIA $5.34
- ALMS N/A
- Average True Range (ATR)
- JMIA 0.38
- ALMS 0.00
- MACD
- JMIA 0.07
- ALMS 0.00
- Stochastic Oscillator
- JMIA 54.94
- ALMS 0.00
About JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.